«Our study is small, retrospective and all of the patients were located at a single medical center, but it demonstrates that it's possible to use molecular diagnostics to identify
subgroups of patients more likely to respond to a given treatment,» said co-first author John Paul Shen, MD, senior clinical fellow and postdoctoral fellow.
Not exact matches
In terms
of cognitive disability, the researchers found that in the
subgroup of MS
patients who underwent neuropsychological testing, those with
more cerebral microbleeds had higher disability on verbal and other cognitive function tests.
The map works by dividing asthma into different
subgroups in order to allow personalised treatment
more targeted to the type
of asthma
patients live with.
This translates into
more accurate diagnostics, new therapy strategies and the development
of patient - focused drugs that can target the different
subgroups of asthma.
He added: «The only positive and continuous result was in the
subgroup of patients who took
more exercise, which means regular exercise at least twice a week, plus the wine consumption.